DISEASE PROGRESSION

Adverse reaction reported in 153,547 FDA reports across 86 drugs.

153,547
Total Reports
86
Drugs Involved
Cyclophosphamide
Most Reported Drug

Drugs Associated with DISEASE PROGRESSION

Drugs where "DISEASE PROGRESSION" was reported as an adverse event.

# Drug Reports % of Total
1 Cyclophosphamide 7,924
5.2%
2 Cyclophosphamide For 7,924
5.2%
3 Dexamethasone 7,337
4.8%
4 Bevacizumab 7,277
4.7%
5 Doxorubicin 6,354
4.1%
6 Capecitabine 6,014
3.9%
7 Carboplatin 5,957
3.9%
8 Cisplatin 4,590
3.0%
9 Gemcitabine 4,461
2.9%
10 Etoposide 4,417
2.9%
11 Oxaliplatin 4,235
2.8%
12 Sunitinib Malate 3,909
2.5%
13 Paclitaxel 3,792
2.5%
14 Trastuzumab 3,492
2.3%
15 Paclitaxel (Aibumin-Bound) 3,335
2.2%
16 Fluorouracil 3,197
2.1%
17 Fluorouracil Cream, 0.5% 3,181
2.1%
18 Cytarabine 2,732
1.8%
19 Docetaxel 2,596
1.7%
20 Thalidomide 2,490
1.6%
21 Bortezomib 2,404
1.6%
22 Palbociclib 2,272
1.5%
23 Bendamustine 2,198
1.4%
24 Ifosfamide 2,089
1.4%
25 Atezolizumab 2,076
1.4%
26 Polatuzumab Vedotin 1,972
1.3%
27 Ibrutinib 1,970
1.3%
28 Letrozole 1,969
1.3%
29 Temozolomide 1,875
1.2%
30 Trifluridine / Tipiracil 1,795
1.2%
31 Everolimus 1,519
1.0%
32 Venetoclax 1,433
0.9%
33 Pemetrexed Disodium 1,370
0.9%
34 Pertuzumab 1,317
0.9%
35 Fulvestrant 1,293
0.8%
36 Crizotinib 1,215
0.8%
37 Axitinib 1,211
0.8%
38 Pemetrexed 1,090
0.7%
39 Fludarabine 1,045
0.7%
40 Bosentan 1,025
0.7%
41 Pazopanib 1,008
0.7%
42 Vincristine 999
0.7%
43 Lapatinib 999
0.7%
44 Fam-Trastuzumab Deruxtecan-Nxki 968
0.6%
45 Exemestane 967
0.6%
46 Filgrastim 909
0.6%
47 Obinutuzumab 899
0.6%
48 Prochlorperazine 787
0.5%
49 Axicabtagene Ciloleucel 785
0.5%
50 Ado-Trastuzumab Emtansine 781
0.5%
51 Vemurafenib 765
0.5%
52 Melphalan 756
0.5%
53 Daratumumab 755
0.5%
54 Leucovorin 750
0.5%
55 Osimertinib 711
0.5%
56 Panitumumab 711
0.5%
57 Carfilzomib 687
0.4%
58 Irinotecan 675
0.4%
59 Azacitidine 640
0.4%
60 Imatinib 625
0.4%
61 Cetuximab 583
0.4%
62 Abiraterone 571
0.4%
63 Voriconazole 525
0.3%
64 Olaparib 492
0.3%
65 Trametinib 491
0.3%
66 Gefitinib 458
0.3%
67 Erlotinib 445
0.3%
68 Ranibizumab 424
0.3%
69 Dabrafenib 415
0.3%
70 Azacitidine For 409
0.3%
71 Bicalutamide 338
0.2%
72 Brentuximab Vedotin 338
0.2%
73 Durvalumab 335
0.2%
74 Lutetium Lu 177 Vipivotide Tetraxetan 322
0.2%
75 Goserelin 317
0.2%
76 Bleomycin 291
0.2%
77 Posaconazole 284
0.2%
78 Mesna 277
0.2%
79 Posaconazole Delayed- 255
0.2%
80 Sirolimus 252
0.2%
81 Encorafenib 230
0.1%
82 Alpelisib 225
0.1%
83 Tafamidis 209
0.1%
84 Thiotepa 193
0.1%
85 Blinatumomab 184
0.1%
86 Acalabrutinib 155
0.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused disease progression. Always consult your healthcare provider.